Signia Therapeutics is very proud to announce it has been awarded with the label “French Tech Seed” by a wide and independent evaluation committee composed of representative of local economic environment (Pouss@Lys). The French Tech Seed is a public fund initiated in July 2018 by French government to support innovative startups in their early development … Continue reading Signia Therapeutics awarded with the label “French Tech Seed”